RHODES JENNIFER J (EVP, CHIEF LEGAL OFFICER, SEC) sold 47.7% of their position (6.95K shares) of ACADIA PHARMACEUTICALS INC on the open market
Open‑market sale worth $162.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/10/2026ACC: 0001568249-26-000002
Officer· EVP, CHIEF LEGAL OFFICER, SEC
Since Mar 2026
-6.95K
Net shares
Net seller
$162.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
12.94K acquired · 19.89K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.94K
Price / share
—
Trade value
—
% of position
801.5%
2/6/2026
1.61K→14.56K
Common Stock
Direct
Shares
−6.95K
Price / share
$23.38
Trade value
$162.49K
% of position
47.7%
2/9/2026
14.56K→7.61K
Total
Net shares
+5.99K
Net value
-$162.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/6/2026 | M · Option Exercise | +12.94K | — | — | 801.5% | 1.61K | 14.56K |
| Common Stock Direct | 2/9/2026 | S · Sale | −6.95K | $23.38 | $162.49K | 47.7% | 14.56K | 7.61K |
| Total | +5.99K | -$162.49K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
12.94K shares
Shares
−12.94K
Strike price
Held after
12.95K
Exercisable
—
2/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock12.94K shares | 2/6/2026 | M · Option Exercise | −12.94K | — | 12.95K |